Chargement en cours...
Lapatinib: the evidence for its therapeutic value in metastatic breast cancer
INTRODUCTION: Breast cancer is the most common cancer affecting women. Many patients ultimately progress to metastatic disease and optimal management of this disease remains a significant therapeutic challenge. Lapatinib, a dual tyrosine kinase inhibitor, is in clinical development for treatment of...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2005
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3321658/ https://ncbi.nlm.nih.gov/pubmed/22500146 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|